You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our Advanced Glycosylation End Product-Specific Receptor (AGER) ELISA Kits

Full name:
Advanced Glycosylation End Product-Specific Receptor ELISA Kits (AGER)
On www.antibodies-online.com are 80 Advanced Glycosylation End Product-Specific Receptor (AGER) ELISA Kits from 19 different suppliers available. Additionally we are shipping Advanced Glycosylation End Product-Specific Receptor Antibodies (284) and Advanced Glycosylation End Product-Specific Receptor Proteins (37) and many more products for this protein. A total of 419 Advanced Glycosylation End Product-Specific Receptor products are currently listed.
Synonyms:
AGER, RAGE
list all ELISA KIts Gene Name GeneID UniProt
AGER 177 Q15109
AGER 11596  
AGER 81722  

Show all species

Show all synonyms

Top referenced Advanced Glycosylation End Product-Specific Receptor ELISA Kits

  1. Mouse (Murine) AGER ELISA Kit for Sandwich ELISA - ABIN1672810 : Neeper, Schmidt, Brett, Yan, Wang, Pan, Elliston, Stern, Shaw: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. in The Journal of biological chemistry 1992 (PubMed)
    Show all 3 references for ABIN1672810

  2. Rat (Rattus) AGER ELISA Kit for Sandwich ELISA - ABIN1672873 : Bierhaus, Haslbeck, Humpert, Liliensiek, Dehmer, Morcos, Sayed, Andrassy, Schiekofer, Schneider, Schulz, Heuss, Neundörfer, Dierl, Huber, Tritschler, Schmidt, Schwaninger, Haering, Schleicher, Kasper et al.: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. ... in The Journal of clinical investigation 2004 (PubMed)
    Show all 2 references for ABIN1672873

More ELISA Kits for Advanced Glycosylation End Product-Specific Receptor Interaction Partners

Human Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. a significant association between RAGE gene rs1800624 polymorphism and breast cancer risk, and more importantly a cumulative impact of multiple risk associated polymorphisms in HMGB1 (show HMGB1 ELISA Kits)/RAGE pathway on breast carcinogenesis, is reported.

  2. This study suggests that advanced glycation end products (AGEs) and activation of AGEs receptor could induce the proliferation of smooth muscle cells from Saphenous vein but not smooth muscle cells from internal thoracic arteryvia MAP kinase (show MAPK1 ELISA Kits) pathway in diabetes mellitus.

  3. Data suggest that in reproductive-aged polycystic ovary syndrome (PCOS) patients, body mass index (BMI) was an independent risk predictive factor of advanced glycation end-products/soluble receptor (show IFNAR1 ELISA Kits) of advanced glycation end-products (AGEs/sRAGE) levels.

  4. this study might provide valuable clinical evidence between the RAGE gene polymorphisms and the risk or the development of sepsis

  5. Study reports the crystallographic structure of an S100-bound full-length RAGE ectodomain. The structure reveals a unique dimeric conformation of RAGE, which appears suited for signal transduction, and shows that the S100A6 (show S100A6 ELISA Kits) protein adopts a non-canonical homodimeric arrangement.

  6. These results indicated that pentamidine blocks the binding between S100A5 (show S100A5 ELISA Kits) and RAGE V domain. This finding is useful for the development of new anti-proliferation drugs.

  7. TREM-1 (show TREM1 ELISA Kits), HMGB1 (show HMGB1 ELISA Kits) and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis

  8. Activation of the RAGE-pathway was shown to be of relevance in patients with septic shock, mainly driven by an increase in immunologic (e.g., S100A8/A9) rather than metabolic ligands (e.g., CML-derived AGE-formation).

  9. Results show that Intrafollicular soluble RAGE levels decrease with age.

  10. Our data shows that subjects with pre-diabetes exhibited low endogenous secreatory RAGE plasma levels and gene expression, which are inversely related with markers of inflammation and atherosclerotic risk.

Cow (Bovine) Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. Our results suggested that the increased RAGE expression in inflammatory circumstances and interaction with AGEs are risk factors in decreasing of aggrecan (show ACAN ELISA Kits) content in nucleus pulposus.

Mouse (Murine) Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. Our results indicate that lack of RAGE has no significant impact on septic arthritis. However, RAGE-/- mice had significantly higher BMD (show BEST1 ELISA Kits) compared to WT mice, which coincided with lower IL-17A (show IL17A ELISA Kits) in RAGE-/- mice. In sepsis, RAGE deficiency impairs bacterial kidney clearance.

  2. SAA (show SAA1 ELISA Kits) is a potential new uremic toxin involved in uremia-related atherosclerosis through interaction with RAGE.

  3. that selective RAGE regulation reflects a self-protective mechanism to maintain low levels of RAGE ligands

  4. Data show that receptor for advanced glycation end products (RAGE) impairs collateral growth in a diabetic setting and also in a non-diabetic setting, indicting the importance of RAGE and alternate RAGE ligands in the setting of collateral vessel growth.

  5. These findings demonstrate the role for RAGE-dependent IL-10 (show IL10 ELISA Kits) suppression as a key modulator of mortality from Gram-negative sepsis.

  6. HMGB1 (show HMGB1 ELISA Kits) promotes intraoral palatal wound healing through RAGE-dependent mechanisms.

  7. These findings suggest that the inhibitory effect of these plant extracts on the activation of AGEs/RAGE/SphK1 (show SPHK1 ELISA Kits) signaling pathway in db/db (show LEPR ELISA Kits) diabetic mice kidney is a novel mechanism by which they exert renoprotective effects in diabetic nephropathy.

  8. Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 (show DIAPH1 ELISA Kits) Signal Transduction.

  9. Interaction of extracellular S100A4 (show S100A4 ELISA Kits) with RAGE prompts prometastatic activation of melanoma cells.

  10. Study demonstrated that 1,25(OH)2D3, the active form of vitamin D, plays an important role in increasing Abeta1-40 vectorial transport from the brain to blood and systemic clearance from peripheral circulation through increasing LRP1 (show LRP1 ELISA Kits) levels both in vivo and in vitro, and reducing RAGE level in the blood-brain barrier model in vitro

Advanced Glycosylation End Product-Specific Receptor (AGER) Antigen Profile

Antigen Summary

The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847).

Alternative names and synonyms associated with Advanced Glycosylation End Product-Specific Receptor (AGER)

  • advanced glycosylation end product-specific receptor (AGER) Elisa Kit
  • advanced glycosylation end product-specific receptor (Ager) Elisa Kit
  • advanced glycosylation end product-specific receptor (LOC100343142) Elisa Kit
  • AGER Elisa Kit
  • RAGE Elisa Kit

Protein level used designations for AGER

advanced glycosylation end product-specific receptor , RAGE isoform NtRAGE-delta , RAGE isoform sRAGE-delta , RAGE/AGER , advanced glycation end product receptor , advanced glycosylation end product-specific receptor variant 1 , advanced glycosylation end product-specific receptor variant 3 , advanced glycosylation end product-specific receptor variant 4 , advanced glycosylation end product-specific receptor variant 5 , advanced glycosylation end product-specific receptor variant 6 , advanced glycosylation end product-specific receptor variant 7 , advanced glycosylation end product-specific receptor variant 8 , receptor for advanced glycosylation end products , advanced glycation end-products receptor , advanced glycosylation end product-specific receptor variant 2

GENE ID SPECIES
462584 Pan troglodytes
177 Homo sapiens
403168 Canis lupus familiaris
396591 Sus scrofa
280986 Bos taurus
11596 Mus musculus
81722 Rattus norvegicus
100343142 Oryctolagus cuniculus
100726130 Cavia porcellus
101111586 Ovis aries
Selected quality suppliers for Advanced Glycosylation End Product-Specific Receptor (AGER) ELISA Kits
Did you look for something else?